Single-Arm, Multicenter, Study to Evaluate Safety and Efficacy of Ultra-Low Frequency Spinal Cord Stimulator in Subjects with Painful Diabetic Neuropathy.
Year: 2021
Type: Device
Phase: Pre-Market
Indication: Painful Diabetic Neuropathy
Efficacy and safety of Transdermal Buprenorphine (Norspan BTDS) and placebo in patients with Diabetic Peripheral Neuropathic Pain (DPNP).
Year: 2011
Type: Pharmaceutical - Pain
Phase: IIIb
Indication: Painful Diabetic Neuropathy
Use of Duloxetine or Pregabalin in Monotherapy versus Combination Therapy of Both Drugs in Patients with Painful Diabetic Neuropathy “The COMBO – DN” (Combination vs Monotherapy of Pregabalin and duloxetine in Diabetic Neuropathy).
Year: 2012
Type: Pharmaceutical - Pain
Phase: IIIb
Indication: Painful Diabetic Neuropathy
A double-blind, placebo-controlled, randomized trial to determine the safety and efficacy of EMA401 100 mg b.i.d. in reducing 24-hour average pain intensity score in patients with painful diabetic neuropathy (EMPADINE).
